China International Capital Corp
-
Viomi Technology, a partner of Chinese smartphone-to-internet company Xiaomi, is looking to float on the Nasdaq for up to $150m.
-
Impro Precision Industries revived its Hong Kong IPO plans on Monday, resubmitting its listing documents to the exchange.
-
The Hong Kong bourse saw a raft of IPO filings this week, as issuers made a beeline for what could be a bumper September for new share sales.
-
The pipeline of Asian IPOs headed for the US is shaping up for September, with the latest crop of issuers all starting to drum up investor interest.
-
Integrated online healthcare provider 111 filed draft documents on Wednesday for a potential $200m issue of American Depository Shares (ADS).
-
China Everbright International hit the market on Tuesday with news of a billion-dollar rights issue, sending its stock price tumbling
-
Hong Kong saw its second biotechnology listing this week, as BeiGene floated on the city’s stock exchange. But two days after listing it was under water and was followed by a double-digit dive by Ascletis Pharma, the sector’s debut issuer. The state of both stocks are a warning sign for future biotech issuers to rein in valuations, say ECM bankers. Jonathan Breen reports.
-
In a quiet week for Asia’s equity capital markets, three issuers filed preliminary documents ahead of their planned share debuts in Hong Kong due to take place in the autumn.
-
Shanghai Junshi Biosciences is eyeing a $500m IPO in Hong Kong, having filed a draft prospectus with the city’s stock exchange.
-
China Everbright Water has mooted a dual-listing of its shares on the Main Board of the Hong Kong Stock Exchange, in a deal bankers say could raise $200m.
-
Chinese local government financing vehicle (LGFV) Wuhan Real Estate Development & Investment Group found enough support to print a $430m bond on Thursday, only the second issuance from the sector in months.
-
Mainland telecommunications infrastructure giant China Tower raised HK$54.3bn ($6.9bn) this week after getting its mammoth float across the line at the bottom of guidance.